Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126751161 | 12675116 | 1 | I | 20160525 | 20160815 | 20160822 | 20160822 | EXP | DE-ACTELION-A-US2016-141133 | ACTELION | 40.00 | YR | A | F | Y | 0.00000 | 20160822 | OT | DE | TR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126751161 | 12675116 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 9ID | Y | 21779 | INHALATION VAPOUR, SOLUTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126751161 | 12675116 | 1 | Pulmonary arterial hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126751161 | 12675116 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126751161 | 12675116 | Asthenia | |
| 126751161 | 12675116 | Cough | |
| 126751161 | 12675116 | Decreased appetite | |
| 126751161 | 12675116 | Muscle rupture | |
| 126751161 | 12675116 | Palpitations | |
| 126751161 | 12675116 | Therapy cessation |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126751161 | 12675116 | 1 | 20160509 | 20160725 | 0 |